Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Mitral Valve Prolapse III: Nursing Management

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Menopause

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Repurposing metformin: is it the new holy grail for longevity?

Maturitas·2026

Same author

Ketogenic diet as a therapeutic intervention for biochemical hyperandrogenism in PCOS women with obesity or overweight: a meta-analytic study.

Journal of endocrinological investigation·2026

Same author

Vascular risk at menopause: The importance of a cardio-gynecological program.

Maturitas·2026

Same author

Uric Acid-to-HDL cholesterol ratio and probable MASLD across adiposity strata in postmenopausal women.

Metabolism open·2026

Same author

The impact of estrogen status on the gut microbiome: a systematic review and meta-analysis.

Frontiers in endocrinology·2026

Same author

Prescribing practices for menopausal hormone therapy in France in 2025: A national online survey (MENOPRAT).

Maturitas·2026

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

EMAS position statement: managing obese postmenopausal women.

Irene Lambrinoudaki¹, Marc Brincat, C Tamer Erel

¹2nd Department of Obstetrics and Gynecology, University of Athens, Aretaieio Hospital, GR-11528 Athens, Greece. ilambrinoudaki@aretaieio.uoa.gr

|May 4, 2010

Summary

Obese postmenopausal women considering hormone therapy (HT) require individualized risk assessment for breast cancer, cardiovascular disease, and venous thromboembolism (VTE). Lower effective doses and transdermal routes are recommended for managing menopause symptoms and preventing osteoporosis.

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

Related Experiment Videos

Last Updated: Jun 13, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

Area of Science:

Reproductive Endocrinology
Menopause Management
Obesity Medicine

Background:

Obesity affects 20% of the global adult population, with higher prevalence (44%) in postmenopausal women.
Obesity is linked to increased risks of diabetes, dyslipidemia, hypertension, gynecologic cancer, cardiovascular disease, and venous thromboembolism.
Menopause management in obese women requires careful consideration of associated health risks.

Framework:

Position statement development based on literature review and expert consensus.
Individualized risk-benefit assessment for hormone therapy (HT) in obese postmenopausal women.
Evaluation of risks (breast cancer, cardiovascular disease, VTE) versus benefits (symptom relief, quality of life, osteoporosis prevention).

Implementation:

Utilize the lowest effective estrogen dose (e.g., CEE 0.300-0.400 mg or estradiol 0.5-1 mg orally; 25-50 microg transdermally).
Consider micronized progesterone or dydrogesterone for progestogen therapy due to potential favorable breast cancer risk profiles.
Transdermal HT is suggested for obese women to potentially reduce venous thromboembolism risk compared to oral administration.

Implications:

Personalized HT regimens are crucial for obese postmenopausal women.
Transdermal estrogen may offer a safer VTE risk profile in this population.
Further research is needed on progestogen efficacy and safety in obese women undergoing HT.